Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of a Single or Multiple Ascending Doses of CPX101 [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating single and multiple ascending doses of CPX101 for safety, tolerability, and pharmacokinetics in adults with overweight or obesity; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• CPX101

Snippet

Sponsor: Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd. | Conditions: Overweight and Obesity | Phase 1 | Status: COMPLETED